Update on Nasdaq initial public offering in the United States

As announced on 18 August 2021, Incannex Healthcare Limited (ASX: IHL, ‘Incannex’ or the ‘Company’) filed a registration statement on Form F-1 with the US Securities and Exchange Commission (the “SEC”). The filing relates to a proposed US public offering (the “Offering”) of American Depositary Shares (“ADSs”), each of which will represent a certain number of ordinary shares of the Company.